US EditionAmericares Honors Teva with Power of Partnership Award
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Americares honors Teva with Power of Partnership Award
STAMFORD, Conn. – Teva Pharmaceuticals has been recognized with the 2025 Power of Partnership Award, presented by Americares in collaboration with the Healthcare Distribution Alliance (HDA), for its exceptional commitment to expanding access to critical medicines globally.The award was presented today at HDA’s Business and Leadership Conference in Orlando, Fla., by Dr. Adam Schwartz, Deputy Medical Officer at Americares. Teva was selected for it…
Vilnius-based UAB Teva Baltics, indirectly controlled by Israeli generic drug giant Teva Pharmaceutical Industries Ltd., last year reduced the production of modern recombinant biopharmaceuticals and increased its share of wholesale drug sales.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
